HOLLY WORTLEY: Open Payments
NPI 1720732308 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 54 payments from 13 companies in 2025. Trend: 2023 $696 · 2024 $886 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $226 |
| AstraZeneca Pharmaceuticals LP | 7 | $175 |
| Indivior Inc. | 8 | $162 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $38 |
| Astellas Pharma US Inc | 2 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Lilly USA, LLC | 2 | $28 |
Products named: VRAYLAR, SUBLOCADE, BREZTRI, AIRSUPRA, Auvelity, QULIPTA, JARDIANCE, REXULTI.
Industry payments across UT — which companies pay providers there.
